Related Experiment Video
Updated: Aug 11, 2025

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
Published on: May 9, 2025
Oncogenic IDH1 Mutation Imparts Therapeutically Targetable Metabolic Dysfunction in Multiple Tumor Types
Troy M Robinson1,2, Ross L Levine1,3,4
1Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Researchers found that cancers with isocitrate dehydrogenase (IDH) mutations have metabolic vulnerabilities. Dysregulated lipid synthesis is a synthetic lethal target in cancers with IDH1 mutations, but not IDH2 mutations.
Area of Science:
- Biochemistry
- Cancer Biology
- Metabolomics
Background:
- Isocitrate dehydrogenase (IDH) mutations are common in various cancers, leading to altered cellular metabolism.
- Understanding the metabolic vulnerabilities associated with IDH mutations is crucial for developing targeted therapies.
Discussion:
- This study investigates the metabolic consequences of IDH mutations using advanced techniques like mass spectrometry metabolomics and stable isotope labeling.
- The research focuses on identifying specific metabolic pathways that become critical for cancer cell survival in the presence of IDH mutations.
Key Insights:
- Cancers with isocitrate dehydrogenase 1 (IDH1) mutations exhibit dysregulated lipid synthesis.
- This dysregulated lipid synthesis represents a synthetic lethal target specifically in IDH1-mutated cancers, offering a potential therapeutic window.
- The findings highlight a metabolic difference between IDH1 and IDH2 mutations regarding lipid metabolism.
Outlook:
- Further research can explore the precise mechanisms of lipid synthesis dysregulation in IDH1-mutated cancers.
- These insights could pave the way for novel therapeutic strategies targeting lipid metabolism in IDH1-mutated cancers.
- Investigating the role of lipid synthesis in IDH2-mutated cancers may reveal distinct vulnerabilities.
More Related Videos
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

